Your new post is loading...
MIT researchers have developed RNA-delivering nanoparticles that allow for rapid screening of new drug targets in mice.
By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion.
